Greenshoe

OneConnect Announces Partial Exercise of Over-Allotment Option in Initial Public Offering

Retrieved on: 
Thursday, January 16, 2020

OneConnect Financial Technology Co. Ltd. (OneConnect or the Company) ( OCFT ), a leading technology-as-a-service platform for financial institutions in China, today announced the closing of the issuance of an additional 3,520,000 American Depositary Shares ("ADSs") of the Company at the initial public offering ( the IPO) price of US$10.0 per ADS, pursuant to the partial exercise of the underwriters' over-allotment option in connection with the IPO.

Key Points: 
  • OneConnect Financial Technology Co. Ltd. (OneConnect or the Company) ( OCFT ), a leading technology-as-a-service platform for financial institutions in China, today announced the closing of the issuance of an additional 3,520,000 American Depositary Shares ("ADSs") of the Company at the initial public offering ( the IPO) price of US$10.0 per ADS, pursuant to the partial exercise of the underwriters' over-allotment option in connection with the IPO.
  • A registration statement related to the offering has been filed with the U.S. Securities and Exchange Commission (the SEC) and declared effective.
  • The offering is made only by means of a prospectus forming a part of the effective registration statement.
  • OneConnect Financial Technology Co., Ltd. (the Company") is a leading technology-as-a-service platform for financial institutions in China.

First Republic Bank Announces Common Stock Offering

Retrieved on: 
Tuesday, January 14, 2020

First Republic Bank (First Republic) (NYSE: FRC), a leading private bank and wealth management company, today announced that it has agreed to sell 2,500,000 shares of its common stock in an underwritten public offering.

Key Points: 
  • First Republic Bank (First Republic) (NYSE: FRC), a leading private bank and wealth management company, today announced that it has agreed to sell 2,500,000 shares of its common stock in an underwritten public offering.
  • First Republic has also granted the underwriters a 30-day option to purchase up to an additional 375,000 shares from First Republic.
  • First Republic intends to use the net proceeds from the offering for general corporate purposes, which may include, among other things, funding loans or purchasing investment securities for its portfolio.
  • Closing of the offering is expected to occur on or about January 17, 2020, subject to customary closing conditions.

cbdMD, Inc. Announces Closing of $18.4 Million Underwritten Public Offering of Common Stock

Retrieved on: 
Tuesday, January 14, 2020

cbdMD sold an aggregate of 18,400,000 shares of its common stock at a purchase price to the public of $1.00 per share in this offering, which included the full exercise by the underwriters of the over-allotment option of 2,400,000 shares of common stock.

Key Points: 
  • cbdMD sold an aggregate of 18,400,000 shares of its common stock at a purchase price to the public of $1.00 per share in this offering, which included the full exercise by the underwriters of the over-allotment option of 2,400,000 shares of common stock.
  • cbdMD, Inc. intends to use the net proceeds from the offering for working capital.
  • ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager for the offering and The Benchmark Company, LLC acted as co-manager for the offering.
  • This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the public offering and the intended use of proceeds from the offering.

Essential Properties Realty Trust, Inc. Announces Pricing of Upsized Primary Public Offering of Common Stock

Retrieved on: 
Friday, January 10, 2020

Essential Properties Realty Trust, Inc. (NYSE: EPRT; the Company) announced today the pricing of an underwritten public offering of 6,900,000 shares of its common stock at a public offering price of $25.20 per share.

Key Points: 
  • Essential Properties Realty Trust, Inc. (NYSE: EPRT; the Company) announced today the pricing of an underwritten public offering of 6,900,000 shares of its common stock at a public offering price of $25.20 per share.
  • The Company has granted the underwriters a 30-day option to purchase up to an additional 1,035,000 shares of common stock.
  • The offering was upsized from the previously announced offering size of 6,250,000 shares of common stock.
  • All of the shares are being offered by the Company, and the offering is expected to close on January 14, 2020.

RADA Announces Pricing of Public Offering of Ordinary Shares

Retrieved on: 
Wednesday, January 8, 2020

NETANYA, Israel, Jan. 08, 2020 (GLOBE NEWSWIRE) -- RADA Electronic Industries Ltd. (RADA) (NASDAQ: RADA), a global defense technology company, today announced the pricing of its underwritten public offering of 4,190,480 of its ordinary shares at a price to the public of $5.25 per share.

Key Points: 
  • NETANYA, Israel, Jan. 08, 2020 (GLOBE NEWSWIRE) -- RADA Electronic Industries Ltd. (RADA) (NASDAQ: RADA), a global defense technology company, today announced the pricing of its underwritten public offering of 4,190,480 of its ordinary shares at a price to the public of $5.25 per share.
  • In addition, RADA has granted the underwriters of the offering a 30-day option to purchase up to an additional 628,572 of its ordinary shares to cover overallotments, if any.
  • Net proceeds from the offering are expected to be approximately $20.3 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by RADA, but excluding any exercise of the underwriters option to purchase additional ordinary shares.
  • RADA intends to use the net proceeds from this offering for general corporate purposes.

Molecular Data Inc. Announces Pricing of Initial Public Offering

Retrieved on: 
Monday, December 30, 2019

SHANGHAI, China, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Molecular Data Inc. (Molecular Data or the Company) (Nasdaq: MKD), a leading technology-driven platform in Chinas chemical industry, today announced that it has priced its initial public offering of 11,500,000 American depositary shares (ADSs) at a price to the public of US$5.38 per ADS for a total offering size of approximately US$61.87 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs.

Key Points: 
  • SHANGHAI, China, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Molecular Data Inc. (Molecular Data or the Company) (Nasdaq: MKD), a leading technology-driven platform in Chinas chemical industry, today announced that it has priced its initial public offering of 11,500,000 American depositary shares (ADSs) at a price to the public of US$5.38 per ADS for a total offering size of approximately US$61.87 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs.
  • The ADSs are expected to begin trading on the Nasdaq Stock Market today under the ticker symbol MKD.
  • The Company has granted to the underwriters an option, exercisable within 30 days from the date of the final prospectus, to purchase up to an aggregate of 1,725,000 additional ADSs at the initial public offering price per ADS.
  • Molecular Data Inc. is a leading technology-driven platform in Chinas chemical industry, connecting participants along the chemical value chain through integrated solutions.

Xebec Announces Closing of $23 Million Bought Deal Public Offering of Common Shares

Retrieved on: 
Friday, December 27, 2019

MONTREAL, Dec. 27, 2019 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. ("Xebec" or the "Corporation") (TSXV:XBC) is pleased to announce it has closed its previously announced bought deal offering, including the exercise in full of the Underwriters' over-allotment option.

Key Points: 
  • MONTREAL, Dec. 27, 2019 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. ("Xebec" or the "Corporation") (TSXV:XBC) is pleased to announce it has closed its previously announced bought deal offering, including the exercise in full of the Underwriters' over-allotment option.
  • A total of 10,952,600 common shares of Xebec (the "Common Shares") were sold at a price of $2.10 per Common Share for aggregate gross proceeds of $23,000,460 (the "Offering").
  • In connection with the Offering, the Corporation paid the Underwriters a cash commission equal to 6% of the gross proceeds of the Offering, and compensation options (the "Compensation Options") equal to 6% of the Common Shares issued pursuant to the Offering.
  • The Common Shares were offered by way of short form prospectus in all of the provinces of Canada.

Healthcare Merger Corp. Announces Closing of $250,000,000 Initial Public Offering

Retrieved on: 
Tuesday, December 17, 2019

New York, NY, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Healthcare Merger Corp. (NASDAQ: HCCOU) (the Company) announced today that it closed its initial public offering of 25,000,000 units, including 3,000,000 units issued pursuant to the exercise by the underwriter of its over-allotment option.

Key Points: 
  • New York, NY, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Healthcare Merger Corp. (NASDAQ: HCCOU) (the Company) announced today that it closed its initial public offering of 25,000,000 units, including 3,000,000 units issued pursuant to the exercise by the underwriter of its over-allotment option.
  • The offering was priced at $10.00 per unit, resulting in gross proceeds of $250,000,000.
  • Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $250,000,000 (or $10.00 per unit sold in the public offering) was placed in trust.
  • This press release contains statements that constitute forward-looking statements, including with respect to the initial public offering and the anticipated use of the net proceeds.

Aptose Announces Proposed Public Offering of Common Shares

Retrieved on: 
Monday, December 16, 2019

SAN DIEGO and TORONTO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose or the Company) (NASDAQ: APTO, TSX: APS), today announced that it has commenced an underwritten public offering of its common shares (the Offering).

Key Points: 
  • SAN DIEGO and TORONTO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose or the Company) (NASDAQ: APTO, TSX: APS), today announced that it has commenced an underwritten public offering of its common shares (the Offering).
  • In addition, Aptose intends to grant the Underwriters a 30-day option to purchase up to an additional 15% of the common shares offered in the Offering.
  • All of the common shares to be sold in the proposed offering will be sold by the Company.
  • No common shares will be offered or sold in Canada as part of this Offering.

SG Blocks Announces Closing of Public Offering

Retrieved on: 
Friday, December 13, 2019

SG Blocks, Inc. (Nasdaq: SGBX) (SG Blocks or the Company), a leading designer, innovator and fabricator of container-based structures, today announced the closing of the previously announced underwritten public offering of 17,150,000 shares of common stock, which includes 2,150,000 shares sold pursuant to the exercise in full by the underwriters of their over-allotment option, at an offering price of $0.15 per share.

Key Points: 
  • SG Blocks, Inc. (Nasdaq: SGBX) (SG Blocks or the Company), a leading designer, innovator and fabricator of container-based structures, today announced the closing of the previously announced underwritten public offering of 17,150,000 shares of common stock, which includes 2,150,000 shares sold pursuant to the exercise in full by the underwriters of their over-allotment option, at an offering price of $0.15 per share.
  • The Company raised total gross proceeds of approximately $2,500,000 in this offering, before deducting underwriting discounts, commissions and other offering expenses payable by the Company.
  • The shares described above are being offered by SG Blocks pursuant to a registration statement on Form S-1, as amended (File No.
  • Each project starts with GreenSteel, the structural core and shell of an SG Blocks building, and then customized to client specifications.